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Abstract
Alternative splicing of pre-mRNA is a highly regulated process that allows cells to change their genetic informational output.
These changes are mediated by protein factors that directly bind specific pre-mRNA sequences. Although much is known
about how these splicing factors regulate pre-mRNA splicing events, comparatively little is known about the regulation of
the splicing factors themselves. Here, we show that the Drosophila splicing factor P element Somatic Inhibitor (PSI) is
phosphorylated at at least two different sites by at minimum two different kinases, casein kinase II (CK II) and tousled-like
kinase (tlk). These phosphorylation events may be important for regulating protein-protein interactions involving PSI.
Additionally, we show that PSI interacts with several proteins in Drosophila S2 tissue culture cells, the majority of which are
splicing factors.
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Introduction
Alternative splicing of pre-mRNA transcripts is widespread
among eukaryotes. It is currently believed that over 90% of human
genes and over 60% of Drosophila multi-exon genes are alterna-
tively spliced [1,2]. The list of splicing events regulated by a
particular protein in a particular cellular context is known for
many factors, usually through the use of RNAi and splicing-
sensitive microarrays or high throughput mRNA-seq [3,4]. Using
splicing-sensitive microarrays, PSI was found to regulate 43
splicing events in S2 cells [5].
PSI was originally identified as a protein factor necessary for the
retention of the third intron of the P element transposon, leading
to the production of a truncated protein [6,7]. PSI, like its
mammalian homologs contains four N-terminal KH-type RNA
binding domains. This repression of splicing occurs through an
interaction between a C-terminal region of PSI and the U1 snRNP
70 K subunit [8,9] and also requires the presence of a PSI binding
motif near the affected intron [10,11]. PSI deletion mutants are
embryonic lethal, and its protein-protein interaction with U1
snRNP 70 K is necessary for male fertility [12].
Although many studies have investigated the effects that splicing
factors have on alternative splicing, few have looked at the
regulation of the factors themselves. Many of these instances of
regulation occur pre-translationally, often at the level of splicing.
For example, many SR proteins regulate their own splicing as well
as that of heterologous SR proteins in a way that shunts those
transcripts into the NMD pathway [13,14].
Some splicing factors are known to be post-translationally
modified. These events can affect the RNA binding capabilities of
the protein [15] as well as the assembly of higher-order structures
like the spliceosome [16]. The spliceosomal proteins SAP155 and
NIPP1 are phosphorylated, and this modification is necessary for
their interaction [17]. SR proteins and other splicing factors are
highly phosphorylated in vivo [18]. Additionally, the RS domain of
the splicing factor ASF/SF2 greatly affects the protein and RNA
binding capabilities of the protein, and is necessary for splicing
[15,19].
We have identified two phosphorylation sites on PSI by mass
spectrometry and identified two kinases that phosphorylate the N-
terminus of PSI. These phosphorylation events may play a role in
the ability of PSI to interact with other proteins. Additionally, we
have identified several interaction partners of PSI, suggesting that
PSI is present in cells a member of large ribonucleoprotein
complexes.
Results
PSI is Phosphorylated in vivo
Using a Polyoma (also known as Glu-Glu) tagged version of PSI,
we purified PSI from Drosophila Kc cells. Interestingly, PSI purified
from Drosophila cells migrated on SDS-PAGE gels as a doublet
(Figure 1A, Figure 4B) while recombinant PSI purified from E. coli
migrated as a single species (Figure 1A). We reasoned that PSI
phosphorylation events occurring in Drosophila cells could be
responsible for the doublet. Consistent with this idea, treatment of
PLOS ONE | www.plosone.org 1 February 2013 | Volume 8 | Issue 2 | e56401
PSI purified from Kc cells with calf intestinal phosphatase (CIP)
collapsed the doublet to a faster migrating band while having no
effect on the migration of recombinantly produced PSI (Figure 1A).
To characterize this apparent phosphorylation, we digested
purified endogenous Drosophila PSI with multiple proteases and
analyzed the resulting peptides by multidimensional chromatog-
raphy/mass spectrometry. The resulting data covered 84.5% of
the sequence to an average depth of 10 observations per peptide.
Manual evaluation of the spectra assigned to phosphopeptides
confirmed two phosphorylation sites at Ser 42 and Ser
61(Figure 1B). Spectra showing phosphorylation at Ser42 were
measured 51 times in four different peptides. Spectra showing
phosphorylation at Ser61 were measured 5 times in two different
peptides. Spectra of the corresponding unmodified peptides were
measured 86 and 5 times, respectively. The characteristics of the
unmodified spectra supported the interpretation of the modified
spectra (Supplemental Figure 1).
The global phosphoproteomic analyses of Drosophila embryos
by Zhai et al. [20] also identified Ser 42 and Ser 61 as
phosphorylation sites. A third site, Ser 85, identified in that study
was not detected on our analysis. Inspection of the supporting data
from Zhai et al for Ser 85 showed that the CID spectrum
contained no neutral loss peak; consequently, the identification is
likely to be a false positive.
PSI is Phosphorylated in Drosophila Cells by Casein
Kinase II
In order to identify the protein kinase or kinases responsible for
the observed phosphorylations of PSI, we used chromatographic
fractionation of Drosophila embryo nuclear extract and followed
PSI-phosphorylating activity using recombinant PSI and radioac-
tive gamma-32P-ATP as substrates (Figure 2A). To simplify the
purification and exclude the phosphorylation of other residues, we
used an N-terminal fragment of PSI that contained only the first
95 amino acids, including the two residues, Ser 42 and Ser 61, that
we identified as being phosphorylated by mass spectrometry
(Figure 1B).
After five purification steps, we analyzed the protein content of
the peak fraction of PSI kinase activity by SDS-PAGE and silver
staining (Figure 2B). We detected two prominent protein species
migrating at approximately 37 and 30 kDa that appeared to be at
stoichiometric levels with each other. We excised these bands, as
well as several other prominent bands, from the gel and performed
mass spectrometry. The 37 and 30 kDa bands were identified as
Figure 1. Biochemcial fractionation and analysis of the PSI kinase. A) Purified recombinant PSI and PSI purified from Kc cells was treated with
calf intestinal phosphatase (CIP) and then visualized by immunoblotting. B) MS2 spectra identifying phosphopeptides found in PSI. B and Y series ions
and neutral loss of phosphate are indicated. Inset: sequence of the phosphopeptide and SEQUEST statistics. MS3 spectra and corresponding spectra
of unmodified peptides are given in supplemental Figure 1.
doi:10.1371/journal.pone.0056401.g001
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the alpha and beta subunits, respectively, of casein kinase II.
Importantly, no other known protein kinases were identified in this
fraction. We calculated the enrichment in specific activity
contained in this fraction to be approximately 12,000-fold relative
to the starting nuclear extract.
Casein kinase II is a tetramer composed of two catalytic 40 kDa
alpha subunits and two regulatory 25 kDa beta subunits [21] and
has many known protein targets in Drosophila [22,23,24,25].
Analytical gel filtration chromatography of the peak activity
fraction of kinase activity showed an approximate size of 135 kDa
for the kinase, consistent with a tetramer composed of two 40 kDa
and two 25 kDa subunits (data not shown).
Casein kinase II has a preferred recognition motif of *SXX(D/
E) [26]. One of the identified phosphorylation sites, Ser 61, lies
within this motif (*SGPE). We therefore hypothesized that casein
kinase II was phosphorylating Ser 61. To confirm this, we made
serine-to-alanine mutants at each phosphorylation site (Ser42 and
Ser61), as well as a double mutant. We used both the peak activity
fraction from the casein kinase II purification as well as purified
recombinant human casein kinase II to phosphorylate these
mutant PSI substrates in vitro (Figure 2C). The mutation of Ser 61
Figure 2. Biochemical purification of Drosophila casein kinase II. A) Purification strategy for endogenous casein kinase II. B) Protein
composition of peak fraction of activity from the final heparin column visualized by SDS-PAGE and silver-staining. Species identified as casein kinase II
alpha and beta are labeled. Bands labeled with an asterisk correspond to contaminating keratin. C) In vitro kinase assay of PSI mutant proteins. Serine
to alanine PSI mutant proteins were phosphorylated in vitro using the peak fraction of activity from the final heparin column and using purified
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to alanine completely abolished to ability of casein kinase II to
phosphorylate the substrate while the mutation of Ser 42 to
alanine had little, if any, effect. Taken together, these data indicate
that Ser 61 in PSI is a casein kinase II phosphorylation site.
PSI is Phosphorylated in Drosophila Cells by Tousled-like
Kinase
Although the majority of the activity in the initial fractionation
step resided in the 1 M KCl fraction and was likely due to casein
kinase II, we detected a smaller peak of activity in the 250 mM
fraction. We further fractionated this peak of activity over several
chromatographic columns (Figure 3A). After fractionation, we
again visualized the peak activity fraction by silver stain (Figure 3B)
and excised prominent bands from the gel and analyzed them by
mass spectrometry. We identified tousled-like kinase (tlk) as a
component of the prominent band migrating at 130 kDa. No
other known protein kinases were identified in this fraction. A
second, independent fractionation also identified tlk as the lone
kinase in the final peak activity fraction.
We then tested the ability of the tlk-containing fraction to
phosphorylate the serine-to-alanine mutant PSI substrates at Ser42
and Ser61 (Figure 3C). Although the tlk-containing fraction did
efficiently phosphorylate the wildtype substrate, it also phosphor-
ylated the two mutants. However, there are one threonine and
fifteen serine residues in the PSI truncation substrate that may
serve as alternate phosphorylation sites for the mutant substrate.
No phosphorylation site could be found in the truncated PSI
substrate by mass spectrometry, suggesting that the observed
activity resulted in very low levels of modification and/or
modification distributed over multiple sites.
PSI Mutants Show Differential Protein Interaction Profiles
PSI contains four RNA-binding KH domains [11], but the
identified phosphorylation sites lie N-terminally to them. The
phosphorylation sites are, however, near a very glycine-rich
region. Glycine-rich regions are known to be mediators of protein-
protein interactions, particularly in RNA binding proteins [27].
We therefore hypothesized that the phosphorylation state of PSI
may influence its ability to interact with other proteins.
To test this idea, we performed GST pulldowns in Drosophila Kc
cell nuclear extract using GST-tagged wildtype and mutant N-
terminal PSI truncations as bait (Figure 4A). As before, these
truncations again consisted of the first 95 amino acids of PSI. We
also performed the pulldowns using bait proteins that had been
pre-phosphorylated by treatment with casein kinase II and ATP.
We then analyzed the PSI-interacting proteins by mass spectrom-
etry.
Interestingly, a 75 kDa protein interacted strongly with the
wildtype and S61A PSI N-terminal truncations, but not with the
S42A or S42A/S61A PSI truncations (Figure 4A). This protein
also seemed to shift in mobility when casein kinase II had been
added to the extract. Mass spectrometry analysis revealed several
peptides of the 75 kDa Recombination Repair Protein 1 (Rrp1) in
the wildtype and S61A pulldowns, but none in the S42A and
S42A/S61A pulldowns. Interestingly, Rrp1 also contains two
copies of the casein kinase II phosphorylation motif, indicating
that its change in mobility when casein kinase II is added to the
pulldown may be the result of its own phosphorylation by CKII.
The ability of Rrp1 to interact with PSI, then, may depend on the
phosphorylation state of Ser 42.
To perform of a more comprehensive analysis of the proteins
that interact with PSI, we expressed epitope-tagged full-length PSI
in S2 cells. We then immunoprecipitated the exogenous PSI using
the polyoma (also known as Glu-Glu) epitope, eluted from this
immunoprecipitation using free polyoma (EYMPME) peptide, and
treated with RNase A. We then immunoprecipitated the eluate
using a polyclonal anti-PSI antibody [28] (Figure 4B, 4C). After
eluting PSI from the antibody resin with acidified glycine, we
analyzed the PSI-interacting proteins using mass spectrometry
(Figure 4D, Supplemental Table 1).
We identified several splicing factors among the interacting
proteins, including snRNP70K, which had been previously shown
to directly interact with the A/B domain of PSI [8]. These PSI-
interacting proteins also included hrp48, a factor known to play a
role in the P element splicing silencer [6,29],the hnRNAP protein
hrp59, the splicing factor PUF68, the RNA helicase Rm62 and SR
protein Srp54. Rrp1, identified as an interacting partner with
truncated PSI, was present but with fewer peptides than proteins
listed in Figure 4D. Interestingly, we also identified several
cytoskeletal proteins, including actin and the alpha and beta
subunits of tubulin. These proteins appear not to be non-specific
contaminants, as they did not co-purify with non-specific rabbit
IgG antibody done in parallel. Taken together, these proteins
appear to associate with PSI via protein-protein interactions in an
RNase-insensitive manner and thus might be functioning along
with PSI in the processing of specific nuclear pre-mRNAs.
Discussion
In this study, we have identified two kinases that phosphorylate
the splicing factor PSI. Although we could definitively show that
the phosphorylation site for casein kinase II was Ser 61, we were
unable to definitively show that Ser 42 was phosphorylated by tlk.
As very little is known about its preferred motif [30], it is difficult
to assess whether tlk can phosphorylate Ser 42. Ser 42 is
additionally in close proximity to several other serines, and thus
its mutation may only shift phosphorylation to one or more of
these nearby sites. However, given that we twice identified tlk as
the only kinase present in a fraction that efficiently phosphorylated
the PSI substrate, it is likely that tlk can phosphorylate PSI.
These phosphorylation events do not occur in or near the RNA-
binding KH domains of PSI and are thus unlikely to modulate
RNA-binding activity. They may, however, affect the protein
interaction partners of PSI. Using GST pulldowns, we showed that
Rrp1 requires the presence of Ser 42 to be able to interact
efficiently with PSI. Rrp1 is an exonuclease that is involved in
DNA damage repair [31]. Connections between splicing and
DNA repair have been previously recognized [32]. Interestingly,
human tlk has also been implicated in DNA damage and repair
[33,34,35]. Furthermore, Ser 42 is conserved between PSI and the
human ortholog of PSI, KSRP. Human KSRP is also phosphor-
ylated upon DNA damage [36], further strengthening a possible
link between the phosphorylation state of PSI and DNA damage
events.
The interaction of PSI with several cytoskeletal proteins was
unexpected. PSI is essentially exclusively nuclear [12], and the
immunoprecipitations and purifications performed here began
with nuclear extracts. Both actin and tubulin, however, are known
to exist in the nucleus [37,38]. Furthermore, certain transcrip-
tional complexes are known to contain actin, and actin has been
shown to interact with several hnRNP proteins [39]. The potential
importance and role of the interaction of PSI with these
cytoskeletal proteins will require further investigation as will a full
understanding of the consequences of these two phosphorylation
events in PSI.
Splicing Factor Phosphorylation
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Materials and Methods
Purification of Polyoma-tagged Full-length PSI from Kc
Cells
Drosophila Kc cells were a gift from the lab of Joan Steitz (Yale
University) and were first produced from 12 hour-old embryos by
Echalier and Ohanessian in 1969 [40]. Nuclear extract from Kc
cells was incubated with 50 mL of anti-polyoma resin for 1 hr at
4uC. The resin was then washed three times with 1 mL IPB2
buffer (20 mM Tris pH 8.0, 2 mM EDTA, 400 mM NaCl, 0.2%
NP-40, 1 mM dithiothreitol). The resin was then resuspended in
500 mL of IPB2 and treated with 0.5 mL of RNase A (Promega).
The resin was then washed twice with 1 mL IPB2, and protein was
eluted off the resin using elution buffer at 65uC (8 M urea/
100 mM Tris pH 8.5). The samples were then prepared for mass
spectrometry as described below.
Purification of N-terminal PSI Truncation
A cDNA fragment containing amino acids 2–95 of PSI was
cloned into pRSETA between the NdeI and KpnI restriction sites.
Additionally, the cDNA contained a His6 tag on the N-terminal
end and a polyoma (EYMPME) tag on the C-terminal end. The
PSI truncation was expressed in BL21(DE3) pLYS E cells and
purified using nickel affinity chromatography.
In vitro Kinase Assays
In vitro kinase assays contained the following: 5 mL fraction to
be assayed, 1 mg PSI fragment, 0.5 mL c-32P-ATP (7000 Ci/
mmol), 25 mM Hepes-KOH, pH 7.5, 0.5 mM EDTA, 5%
Figure 3. Purification of a second PSI kinase activity. A) Purification strategy for tousled-like (tlk) kinase. B) Protein composition of peak
fraction activity from the final Mono S column visualized by silver staining. The species identified as tlk is labeled. C) In vitro kinase assay of PSI
mutants. Serine to alanine PSI mutants were phosphorylated in vitro using the peak fraction of activity from the final Mono S column. Assays were
visualized using autoradiography, and, to ensure equal protein loading, silver staining.
doi:10.1371/journal.pone.0056401.g003
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glycerol, 5 mM MgCl2, 100 mM KCl, 0.5 mM DTT, 0.4 mM
PMSF, 10 mM NaF, 5 mM beta-glycerol-phosphate, 25 mM ATP
in a final volume of 50 mL. The reactions were incubated at room
temperature for 30 min. Ten mL of protein sample buffer were
added, and 15 microliters of the sample was then analyzed by
SDS-PAGE. The gel was silver-stained, dried, and exposed to X-
ray film for two hours to determine the chromatography fractions
that contained PSI-phosphorylating activity.
GST Pulldowns
cDNA fragments for each PSI mutant were cloned into pGEX-
2TK and expressed as GST fusions in Rosetta(DE3) pLYS S E. coli
cells. Lysate containing the overexpressed PSI fusion proteins was
incubated with glutathione-sepharose beads for 3 hr at 4uC. The
beads were then washed 3 times with Buffer A (50 mM Tris-HCl,
pH 8.0, 1 M NaCl, 0.5 mM DTT, 0.4 mM PMSF, 10% glycerol)
and 2 times with 1X Casein Kinase II buffer (NEB P6010S). ATP
was then added to all samples to 5 mM, and 1 uL purified human
casein kinase II (NEB P6010S) was added to those samples that
were to be phosphorylated. The samples were then incubated
overnight at 30uC.
100 mL Kc nuclear extract was then added, and the beads were
incubated at 4uC for 3 hrs. The beads were then washed three
times with buffer B (20 mM Tris-HCl, pH 8.0, 200 mM NaCl,
0.02% NP-40, 0.5 mM DTT, 0.4 mM PMSF), and bound
proteins were eluted by incubating with 50 mL elution buffer
Figure 4. Protein-protein interactions of PSI. A) GST pulldown assay using PSI mutant proteins. GST-PSI fusion proteins carrying the serine to
alanine PSI mutations were phosphorylated using purified human casein kinase II and incubated with Kc nuclear extract. The resulting glutathione
resin eluates were analyzed by silver staining and mass spectrometry. B) Silver stain of PSI and interacting proteins following anti-polyoma and anti-
PSI immunoprecipitations. The asterisk indicates antibody heavy chain. C) Immunoblot analysis of (B) using anti-PSI antibody. D) Mass spectrometry
analysis of (B). Proteins identified as interacting with PSI and the number of peptides observed for each protein are listed.
doi:10.1371/journal.pone.0056401.g004
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(50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 10% glycerol, 20 mM
glutathione, 0.5 mM DTT, 0.4 mM PMSF) at room temperature
for 45 min. Bound proteins were analyzed by SDS-PAGE, silver-
staining, and mass spectrometry.
PSI Immunoprecipitation
RNP extract [41,42] from Drosophila S2 cells stably expressing
polyoma (also known as Glu-Glu) tagged PSI under the control of
the metallothionein promoter was made after inducing expression
of the transgene with 200 mM CuSO4 for 36 hours. Briefly, cells
were swelled in hypotonic buffer and nuclei were isolated using a
dounce homogenizer. The nuclei were then sonicated, and the
resulting lysate was passed over a 30% sucrose cushion to separate
the light nucleoplasm from the dense chromatin-associated
fraction.
The nucleoplasm was then collected and incubated at 4uC for
2 hrs with protein-A sepharose beads that had been pre-incubated
with anti-polyoma antibody. The beads were then washed 3 times
with wash buffer (20 mM Hepes-KOH pH 7.5, 200 mM KCl,
2 mM MgCl2, 0.5 mM DTT, 0.05% NP-40, 0.4 mM PMSF).
Proteins were then eluted from the resin by two incubations with
200 mL elution buffer (wash buffer supplemented with 100 mg/mL
polyoma peptide (EYMPME)).
Elutions were then incubated for 1 hr at 4uC with protein-A
Dynabeads (Invitrogen 100-01D) that had been pre-incubated
with polyclonal anti-PSI antibody. As a control, the elutions were
also incubated with protein-A Dynabeads that had been pre-
incubated with rabbit IgG.The beads were then washed three
times with wash buffer. Bound proteins were eluted off the beads
in two elutions by incubating with 100 mL elution buffer (100 mM
glycine, pH 2.5, 100 mM NaCl). The eluates from both the anti-
PSI and rabbit IgG beads were analyzed by silver staining, western
blotting, and mass spectrometry. Proteins identified as interacting
with PSI by having at least 5 detected peptides are listed in
Figure 4D.
Sample Preparation and Mass Spectrometry for
Phosphopeptide Analysis
Immunopurified PSI was adjusted to 40% methanol, 100 mM
ammonium bicarbonate pH8.5, 5 mM TCEP, 1.5% Protease-
MAX (Promega) and subjected to carboxyamidomethylation of
cysteines. Two samples were created and analyzed separately and
then the results were combined. The first sample was digested with
trypsin and chymotrypsin. The second sample was divided, and
one portion was digested with a combination of trypsin and
chymotrypsin. The other portion was digested with thermolysin.
The two fractions were then recombined for analysis. All
digestions were incubated overnight at 37uC and stopped by the
addition of 5% formic acid. A 3 phase nano LC column was
packed in a 100 mm inner diameter glass capillary with an emitter
tip. The column consisted of 10 cm of Polaris C18 5 mm packing
material (Varian), followed by 4 cm of Partisphere 5 SCX
(Whatman), followed by another 2 cm of Polaris C18. The
column was loaded by use of a pressure bomb and washed
extensively with buffer A (see below). The column was then
directly coupled to an electrospray ionization source mounted on a
Thermo-Fisher LTQ XL linear ion trap mass spectrometer. Data
collection was programmed so that neutral loss of phosphate
would tigger the collection of an MS3 spectrum of the neutral loss
peak. An Agilent 1200 HPLC equipped with a split line so as to
deliver a flow rate of 30 nl/min was used for chromatography.
Peptides were eluted using a 4-step MudPIT procedure [43].
Buffer A was 5% acetonitrile/0.02% heptaflurobutyric acid
(HBFA); buffer B was 80% acetonitrile/0.02% HBFA. Buffer C
was 250 mM ammonium acetate/5% acetonitrile/0.02% HBFA;
buffer D was same as buffer C, but with 500 mM ammonium
acetate. The programs SEQUEST and DTASELECT were used
to identify peptides and proteins from the Drosophila database
[44,45]. Phosphopeptides were confirmed by manual inspection of
the spectra.
Sample Preparation and Mass Spectrometry for Protein
Interaction Analysis
The protein solution was adjusted to 8 M urea, subjected to
carboxyamidomethylation of cysteines, and digested with trypsin.
The sample was then desalted using a C18 spec tip (Varian). A 2
phase nano LC column was packed and loaded as described
above. The column consisted of 10 cm of Polaris C18 5 mm
packing material (Varian), followed by 4 cm of Partisphere 5 SCX
(Whatman). Chromatography, mass spectrometry and data
analysis were as described above, except that no MS3 spectra
were collected.
Mass Spectrometry of Gel Bands
Excised gel bands were treated to cause carboxyamidomethyla-
tion of cysteines, digested with trypsin and the resulting peptides
extracted. Samples were loaded on a 100 micromolar ID, 10 cm
column of Polaris C18 and analyzed by LC-MS/MS with a linear
gradient consisting of buffer A and buffer B as above.
Supporting Information
Figure S1 Identification of phosphorylation sites by
mass spectrometry. A and B) MS3 spectra of phosphopep-
tides. B and Y series ions and loss of water are indicated. Inset:
sequence of the phosphopeptide and SEQUEST statistics. C and
D) MS2 spectra of corresponding unmodified peptides.
(EPS)
Table S1 Protein-protein interactions of PSI. Proteins
identified with at least two peptides as copurifying in pulldowns of
full length PSI. SEQUEST Xcorr is listed for each peptide.
(XLS)
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